Company Profile

Jiangsu LYDRAGEN Minimally Invasive Surgical Medical Technology Co., Ltd.

       Founded in 2022, Jiangsu LYDRAGEN Minimally Invasive Surgical Medical Technology Co., Ltd. (hereinafter referred to as “LYDRAGEN”) is a global enterprise integrating research and development, production, and marketing. Our company is located in the east zone of Medpark, Suzhou New District, surrounded by a picturesque environment and convenient transportation. We have a production workshop with a cleanliness level of 100,000 and a laboratory with a cleanliness level of 10,000, both of which are GMP certified. In addition, we have purchased cutting-edge production and inspection equipment. Since the inception of our company, we have adhered to the “customer-centric, patient-oriented” marketing strategy, emphasizing a high-quality approach and carving out a path that closely follows market trends in the field of minimally invasive medical devices, enabling our company to swiftly adapt to market changes. LYDRAGEN dives deep into the field of minimally invasive surgery, gains insights into market demands, and emphasizes R&D investment. It maintains close cooperative relationships with universities such as Shandong University, Ocean University of China, etc. We are dedicated to developing more products with independent intellectual property rights, striving to bring benefits to a wide range of patients, and providing social and economic benefits to medical institutions.
       As early as its establishment, we aspired to develop LYDRAGEN into a prestigious enterprise that is publicly traded, rigorously standardized, and enduringly sustainable. It is complemented by an open, standardized, and state-of-the-art mechanism of business management, along with a development strategy that is unwaveringly focused on advancing minimally invasive medical devices. Our company independently pioneers the ENDINTEL® (Generation I), ENDSAI® 2000 (Generation II), and ENDSAI® 3000 (Generation III) series of fully electric intelligent endoscope cutting stapler series products, adhering to the quality policy of “lean production, quality first; sustainable innovation, customer centricity”. It establishes a comprehensive intelligent endoscope cutting and anastomosis platform for minimally invasive surgery, aspiring to become a preeminent intelligent authority in the realm of minimally invasive surgical technology. We are embracing a trajectory of sustained and stable growth, eagerly seeking to collaborate with individuals from diverse backgrounds and industries to forge a brighter future for all!